A Study To Evaluate Role of Brahmyadi churna and Ashvagandha churna with Satwavjaya chikitsa in Anxiety.
- Conditions
- Health Condition 1: F411- Generalized anxiety disorder
- Registration Number
- CTRI/2024/07/070479
- Lead Sponsor
- Dr Anupam
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Subjects fulfilling criteria based on DSM-5 and those getting score between 8-23 in Hamilton Anxiety Rating Scale will be included in the study.
2.Subjects suffering from GAD for a minimum period of atleast 6 months
3.Subjects between age group of 20 to 60 years irrespective of gender.
4.Subjects willing to sign consent form.
1.Subjects on use of anxiolytics or antidepressants in the previous 6 months.
2.Subjects diagnosed with other psychiatric illnesses like mood disorder, psychosis, depression etc. from past 12 months.
3.Subjects suffering from Generalised anxiety disorder associated with other serious systemic illnesses that would interfere with the treatment.
4.Subjects with uncontrolled hypertension , diabetes mellitus , thyroid dysfunction, renal dysfunction, organic mental disorder or psychoactive-substance related disorder, such as excess consumption of alcohol, amphetamine-like substances, or withdrawal from benzodiazepines.
5.Pregnant and Lactating Women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Significant decrease in signs and symptoms of GAD assessment based on Hamilton Anxiety rating ScaleTimepoint: Before intervention- 0th <br/ ><br>After intervention- 28th <br/ ><br>Follow Up- 43rd day.
- Secondary Outcome Measures
Name Time Method Generation of in depth analysed data on different aspect of Disease . <br/ ><br>Generation of Data on possible unexpected drug reactionTimepoint: Before intervention- 0th <br/ ><br>After intervention- 28th <br/ ><br>Follow Up- 43rd day.